Evidence map›Paper›PMID 24284320›Full record

ArticleJournal of virology2014

The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses.

Frederic Vigant, Axel Hollmann, Jihye Lee, Nuno C Santos, Michael E Jung, Benhur Lee

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 70 citations in OpenAlex.

  1. Membrane-Targeting Antivirals.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Lipid and Lipidation in Membrane Fusion.The Journal of membrane biology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Computational methods to study enveloped viral entry.Biochemical Society transactions · 2021
    Review
  16. Photosensitizing Antivirals.Molecules (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Frederic VigantDepartment of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, California, USA.
Axel Hollmann
Jihye Lee
Nuno C Santos
Michael E Jung
Benhur Lee
University of California, Los Angeles · USUniversity of Lisbon · PT

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Broad spectrum therapeutics that target the viral membraneU01AI082100 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEE, BENHUR · 2009 to 2012
$3.0M
Small Molecule Inhibitors of Nipah and Hendra Virus InfectionU01AI070495 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEE, BENHUR · 2006 to 2009
$2.8M
Envelope-receptor interactions in Nipah and Hendra virus pathobiologyR01AI069317 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEE, BENHUR · 2007 to 2011
$1.7M
NIAID NIH HHS R01 AI069317NIAID NIH HHS U01 AI070495NIAID NIH HHS U01 AI082100NIAID NIH HHS U54 AI065359
6 · The paper itself

Abstract

Rigid amphipathic fusion inhibitors (RAFIs) are lipophilic inverted-cone-shaped molecules thought to antagonize the membrane curvature transitions that occur during virus-cell fusion and are broad-spectrum antivirals against enveloped viruses (Broad-SAVE). Here, we show that RAFIs act like membrane-binding photosensitizers: their antiviral effect is dependent on light and the generation of singlet oxygen ((1)O(2)), similar to the mechanistic paradigm established for LJ001, a chemically unrelated class of Broad-SAVE. Photosensitization of viral membranes is a common mechanism that underlies these Broad-SAVE.

Indexed as

Antiviral AgentsCell MembraneHerpes SimplexHerpesvirus 1, HumanHumansLightVirus InternalizationAntiviral Agents

Identifiers

PMID24284320
PMCPMC3911596
OpenAlexW2027083299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.